arrow
Back
R

Rahul Aggarwal

university of miami

21H-index
130Paper Count
2.0KCitation Count
Published Papers 56
Publication Date
Knowledge, attitudes, behaviors, and consequences of geogenic fluoride exposure on oral and dental health in Nakuru, Kenya
err2026-03-20
err0
errOAAI
errOkore, Lavender Awino; Aggarwal, Rahul; Awuor, Diana Ross; Owuor, Patrick Mbullo
errShare
errSave
Cardiovascular Outcomes with Icosapent Ethyl by Burden of Standard Modifiable Cardiovascular Risk Factors in REDUCE-IT
err2026-02-02
err0
errOAAI
errRahul Aggarwal; Deepak L. Bhatt; Michael Miller; Christie M. Ballantyne; Eliot A. Brinton; Terry A. Jacobson; Steven B. Ketchum; Jean-Claude Tardif; Matthew J. Budoff; Gemma A. Figtree; Ph. Gabriel Steg
errShare
errSave
Efficacy of sotagliflozin among older adults: a pooled analysis of SCORED and SOLOIST-WHF
err2025-11-05
err0
PREAI
errR Aggarwal; D L Bhatt; M Szarek; M J Davies; B Pitt; P G Steg
errShare
errSave
Validation of the DOAC Score among patients on vitamin K antagonists
err2025-11-05
err0
PREAI
errR Aggarwal; C T Ruff; M G Palazzolo; F C Buttner; J Eikelboom; M Patel; C Granger; L Wallentin; Z Hijazi; S Virdone; P Zimetbaum; E A Secemsky; A K Kakkar; R P Giugliano; R W Yeh
errShare
errSave
Efficacy and safety of rapid up-titration of medical therapies for heart failure by ischemic and non-ischemic etiologies: an analysis of STRONG-HF
err2025-11-05
err0
PREAI
errR Aggarwal; D L Bhatt; A Mebazaa; B Davison; O Chioncel; M Metra; P Ponikowski; K Sliwa; A Voors; C Edwards; C Cotter
errShare
errSave
Cardiovascular-Kidney-Metabolic Syndrome-Attributable Mortality in the United States, From 2010 to 2023
err2025-11-01
err0
errOAAI
errZuin, Marco; Aggarwal, Raul; Khera, Amit; Hermes, Zachary; Bilato, Claudio; Piazza, Gregory
errShare
errSave
Real-World Characteristics of JAKne: A 14-Year Retrospective Cohort Study
err2025-09-15
err0
PREAI
errPeyton V. Warp; Grace Garrett; Rahul Aggarwal; Andrea D. Maderal; Scott A. Elman
errShare
errSave
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population
err2025-06-01
err0
errOAAI
errAggarwal, Rahul; Bhatt, Deepak L.; Bonaca, Marc P.; Deck, Catrin; Lesogor, Anastasia; Patel, Manesh R.; Stroes, Erik S. G.; Taub, Pam R.; Windecker, Stephan
errShare
errSave
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial
err2025-02-19
err0
errOAAI
errAggarwal, Rahul; Bhatt, Deepak L.; Steg, Ph. Gabriel; Miller, Michael; Brinton, Eliot A.; Dunbar, Richard L.; Ketchum, Steven B.; Tardif, Jean-Claude; Martens, Fabrice M. A. C.; Ballantyne, Christie M.; Szarek, Michael; Mason, R. Preston; REDUCE IT Investigators
errShare
errSave
Trends in Sudden Cardiac Death Among Adults Aged 25 to 44 Years in the United States: An Analysis of 2 Large US Databases
err2025-01-07
err1
PREAI
errZuin, Marco; Mohanty, Sanghamitra; Aggarwal, Rahul; Bertini, Matteo; Bikdeli, Behnood; Hamade, Nada; Leyva, Hannah; Natale, Andrea; Boriani, Giuseppe; Piazza, Gregory
errShare
errSave
Substantial cardiovascular risk reduction with icosapent ethyl in patients with prior cardiovascular events regardless of coronary artery disease history: REDUCE-IT CAD
err2024-11-12
err0
PREAI
errAggarwal, Rahul; Bhatt, Deepak; Ballantyne, Christie; Miller, Michael; Brinton, Eliot; Jacobson, Terry; Ketchum, Steven; Pineda, Armando Lira; Doyle, Ralph; Tardif, Jean-Claude; Steg, Philippe
errShare
errSave
Cardiovascular risk factors and disease mortality among asian american subgroups
err2024-10-28
err0
PREAI
errAggarwal, R.; Wadhera, R.; Szarek, M.; Bhatt, D.
errShare
errSave
Efficacy of sotagliflozin by diabetes duration: a secondary analysis of SCORED
err2024-10-28
err0
PREAI
errAggarwal, R.; Bhatt, D.; Szarek, M.; Davies, M.; Banks, P.; Pitt, B.; Steg, G.
errShare
errSave
Applicability of VICTORION-1 PREVENT Criteria to the US Population
err2024-10-28
err0
PREAI
errAggarwal, R.; Bhatt, D.; Bonaca, M.; Deck, C.; Lesogor, A.; Patel, M.; Stroes, E.; Taub, P.; Windecker, S.
errShare
errSave
Icosapent ethyl by baseline small dense low-density lipoprotein cholesterol: an analysis of REDUCE-IT
err2024-10-28
err0
PREAI
errAggarwal, R.; Bhatt, D.; Steg, G.; Miller, M.; Brinton, E.; Dunbar, R.; Martens, F.; Ketchum, S.; Tardif, J.; Mason, P.; Ballantyne, C.
errShare
errSave
Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to US Adults With Heart Failure
err2024-09-01
err1
errOAAI
errOstrominski, John W.; Aggarwal, Rahul; Claggett, Brian L.; Kulac, Ian J.; Desai, Akshay S.; Jhund, Pardeep S.; Lam, Carolyn S. P.; Pitt, Bertram; Senni, Michele; Shah, Sanjiv J.; Voors, Adriaan A.; Zannad, Faiez; Lay-Flurrie, James; Viswanathan, Prabhakar; McMurray, John J. V.; Solomon, Scott D.; Vaduganathan, Muthiah
errShare
errSave
errShare
errSave
Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial
err2024-04-17
err0
errOAAI
errAggarwal, Rahul; Bhatt, Deepak L.; Szarek, Michael; Leiter, Lawrence A.; Cannon, Christopher P.; Lopes, Renato D.; Davies, Michael J.; Banks, Phillip; Pitt, Bertram; Steg, Ph. Gabriel
errShare
errSave